title: Treatment of pre-ulcerative necrobiosis lipoidica with infliximab.
authors.forename: Héléne
authors.initials: H
authors.lastname: Conte
authors.forename: Brigitte
authors.initials: B
authors.lastname: Milpied
authors.forename: Mamadou
authors.initials: M
authors.lastname: Kaloga
authors.forename: Nathalie
authors.initials: N
authors.lastname: Lalanne
authors.forename: Emilie
authors.initials: E
authors.lastname: Belin
authors.forename: Thomas
authors.initials: T
authors.lastname: Jouary
authors.forename: Alain
authors.initials: A
authors.lastname: Taieb
authors.forename: Khaled
authors.initials: K
authors.lastname: Ezzedine
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D000069285:Infliximab; D008297:Male; D009335:Necrobiosis Lipoidica / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D012867:Skin / Q000187:drug effects* / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D000069285:Infliximab